Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID after Pfizer Shot; COVID after Pfizer Shot; This is a spontaneous report and received from Consumer or other non HCPs. A 70-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "COVID after Pfizer Shot". Clinical course: During an inbound call for financial assistance the patient stated, looking into some insurance for COVID. He was in the hospital now. He was in a sniff (SNF) unit. After confirming his insurance, he stated, he was in a sniff (SNF) unit so they were going to get the medication here. After confirming that he was currently at the hospital and been prescribed the medication, he replied, yes. It was for the COVID virus, COVID meds. He was taking Pfizer Shot to keep from catching it. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.